Af­ter snatch­ing up Shire's can­cer unit, French phar­ma gi­ant Servi­er to ex­pand US pres­ence with Kendall Square in­no­va­tion of­fice

Servi­er, the French phar­ma gi­ant that just ac­quired Shire’s on­col­o­gy unit for $2.4 bil­lion, is putting a US in­no­va­tion out­post in Kendall Square. The new unit will be called Servi­er BioIn­no­va­tion, and it’s just re­cruit­ed two ex­ec­u­tives to head it up — like­ly hunters for part­ner­ships and tech that will ad­vance Servi­er’s pipeline.

This marks the sec­ond French phar­ma gi­ant to an­nounce a Kendall Square out­post in the past 24 hours. Just yes­ter­day, Ipsen an­nounced it was mov­ing its US head­quar­ters from New Jer­sey to Boston.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.